AVBP Insider Trading

AVBP · full profile →Last filing Jun 18, 2026
Mixed · 180d
Open-Market Buys (180d)
$0
0 insiders
Open-Market Sells (180d)
$0
0 insiders
Net Insider Flow
$0
open market, 180d
Reporting Insiders
0
0 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Recent Form 4 Transactions

68 shown
DateInsiderRoleActionSharesPriceValue
Jun 18, 2026Parsey MerdadDirectorGrant(A)14K$0
Jun 18, 2026Peterson KristineDirectorGrant(A)14K$0
Jun 18, 2026Hohneker JohnDirectorGrant(A)14K$0
Jun 18, 2026Nolet ChrisDirectorGrant(A)14K$0
Feb 2, 2026Kastenmayer James PaulGeneral CounselGrant(A)130K$0
Feb 2, 2026Yao ZhengbinPresident and CEO, DirectorGrant(A)550K$0
Feb 2, 2026Kung WinstonChief Financial OfficerGrant(A)140K$0
Feb 2, 2026Lutzker StuartPresident of R&D, DirectorGrant(A)150K$0
Feb 2, 2026LaChapelle RobinChief Operating OfficerGrant(A)130K$0
Dec 10, 2025HHLR Advisors, LTD.10% OwnerSell(S)556K$23.37$13.0M
Jul 11, 2025LaChapelle RobinChief Operating OfficerOption exercise(M)2K$2.28$5K
Jul 11, 2025LaChapelle RobinChief Operating OfficerOption exercise(M)7K$2.28$15K
Jul 11, 2025LaChapelle RobinChief Operating OfficerOption exercise(M)3K$2.28$6K
Jul 11, 2025LaChapelle RobinChief Operating OfficerOption exercise(M)3K$0
Jul 11, 2025LaChapelle RobinChief Operating OfficerOption exercise(M)7K$0
Jul 11, 2025LaChapelle RobinChief Operating OfficerOption exercise(M)2K$0
Jun 18, 2025Nolet ChrisDirectorGrant(A)16K$0
Jun 18, 2025Hohneker JohnDirectorGrant(A)16K$0
Jun 18, 2025Peterson KristineDirectorGrant(A)16K$0
Jun 18, 2025Parsey MerdadDirectorGrant(A)16K$0
Apr 28, 2025Parsey MerdadDirectorGrant(A)28K$0
Feb 3, 2025Kastenmayer James PaulGeneral CounselGrant(A)102K$0
Feb 3, 2025Kung WinstonChief Financial OfficerGrant(A)120K$0
Feb 3, 2025LaChapelle RobinChief Operating OfficerGrant(A)120K$0
Feb 3, 2025Lutzker StuartPresident of R&D, DirectorGrant(A)120K$0
Feb 3, 2025Yao ZhengbinPresident and CEO, DirectorGrant(A)380K$0
Sep 19, 2024LaChapelle RobinChief Operating OfficerOption exercise(M)2K$2.28$6K
Sep 19, 2024LaChapelle RobinChief Operating OfficerOption exercise(M)12K$3.65$45K
Sep 19, 2024LaChapelle RobinChief Operating OfficerOption exercise(M)7K$2.28$16K
Sep 19, 2024LaChapelle RobinChief Operating OfficerOption exercise(M)3K$6.24$17K
Sep 19, 2024LaChapelle RobinChief Operating OfficerOption exercise(M)3K$2.28$7K
Sep 19, 2024LaChapelle RobinChief Operating OfficerOption exercise(M)2K$0
Sep 19, 2024LaChapelle RobinChief Operating OfficerOption exercise(M)3K$0
Sep 19, 2024LaChapelle RobinChief Operating OfficerOption exercise(M)7K$0
Sep 19, 2024LaChapelle RobinChief Operating OfficerOption exercise(M)12K$0
Sep 19, 2024LaChapelle RobinChief Operating OfficerOption exercise(M)3K$0
May 16, 2024Hohneker JohnDirectorGrant(A)30K$0
Apr 22, 2024Peterson KristineDirectorGrant(A)29K$0
Jan 30, 2024HHLR Advisors, LTD.10% OwnerConversion(C)313K
Jan 30, 2024HHLR Advisors, LTD.10% OwnerBuy(P)556K$18.00$10.0M
Jan 30, 2024HHLR Advisors, LTD.10% OwnerConversion(C)3.6M
Jan 30, 2024HHLR Advisors, LTD.10% OwnerConversion(C)55.0M$0
Jan 30, 2024HHLR Advisors, LTD.10% OwnerConversion(C)4.8M$0
Jan 30, 2024Healy JamesDirectorConversion(C)1.3M
Jan 30, 2024Healy JamesDirectorBuy(P)444K$18.00$8.0M
Jan 30, 2024Healy JamesDirectorConversion(C)1.3M
Jan 30, 2024Gordon Carl LDirector, 10% OwnerConversion(C)470K
Jan 30, 2024Gordon Carl LDirector, 10% OwnerBuy(P)222K$18.00$4.0M
Jan 30, 2024Gordon Carl LDirector, 10% OwnerConversion(C)470K
Jan 30, 2024Gordon Carl LDirector, 10% OwnerConversion(C)822K
Jan 30, 2024Gordon Carl LDirector, 10% OwnerConversion(C)822K
Jan 30, 2024Gordon Carl LDirector, 10% OwnerBuy(P)222K$18.00$4.0M
Jan 30, 2024Gordon Carl LDirector, 10% OwnerConversion(C)470K
Jan 30, 2024Gordon Carl LDirector, 10% OwnerConversion(C)822K
Jan 30, 2024Gordon Carl LDirector, 10% OwnerConversion(C)470K
Jan 30, 2024Gordon Carl LDirector, 10% OwnerConversion(C)822K
Jan 30, 2024OrbiMed Asia GP IV, L.P.Director, 10% OwnerBuy(P)222K$18.00$4.0M
Jan 30, 2024OrbiMed Asia GP IV, L.P.Director, 10% OwnerBuy(P)222K$18.00$4.0M
Jan 30, 2024OrbiMed Asia GP IV, L.P.Director, 10% OwnerConversion(C)470K
Jan 30, 2024OrbiMed Asia GP IV, L.P.Director, 10% OwnerConversion(C)470K
Jan 30, 2024OrbiMed Asia GP IV, L.P.Director, 10% OwnerConversion(C)822K
Jan 30, 2024OrbiMed Asia GP IV, L.P.Director, 10% OwnerConversion(C)822K
Jan 30, 2024OrbiMed Asia GP IV, L.P.Director, 10% OwnerConversion(C)822K
Jan 30, 2024OrbiMed Asia GP IV, L.P.Director, 10% OwnerConversion(C)822K
Jan 30, 2024OrbiMed Asia GP IV, L.P.Director, 10% OwnerConversion(C)470K
Jan 30, 2024OrbiMed Asia GP IV, L.P.Director, 10% OwnerConversion(C)470K
Jan 25, 2024Jallal BahijaDirectorGrant(A)18K$0
Jan 25, 2024Nolet ChrisDirectorGrant(A)18K$0

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Coverage: Form 4 filings indexed 2021-03-292026-07-11. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).